114 related articles for article (PubMed ID: 7509185)
1. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
Kirkpatrick JN; Dick AD; Forrester JV
Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
[TBL] [Abstract][Full Text] [Related]
2. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
Jaakkola A; Anttila PM; Immonen I
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
[TBL] [Abstract][Full Text] [Related]
5. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
Thoelen A; Menozzi M; Huber C; Messmer E
Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
[TBL] [Abstract][Full Text] [Related]
6. Interferon alfa-2a in the treatment of exudative age-related macular degeneration.
Lewis ML; Davis J; Chuang E
Graefes Arch Clin Exp Ophthalmol; 1993 Nov; 231(11):615-8. PubMed ID: 8258394
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
Kertes PJ; Britton WA; Leonard BC
Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
[No Abstract] [Full Text] [Related]
8. Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.
Engler C; Sander B; Villumsen J; Lund-Andersen H
Br J Ophthalmol; 1994 Oct; 78(10):749-53. PubMed ID: 7528534
[TBL] [Abstract][Full Text] [Related]
9. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.
Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green angiography in age-related macular degeneration with occult neovascularization.
Pece A; Introini U; Bolognesi G; Brancato R
Ophthalmologica; 1998; 212(5):295-300. PubMed ID: 9693284
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
[TBL] [Abstract][Full Text] [Related]
12. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
Thomas MA; Ibanez HE
Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
[TBL] [Abstract][Full Text] [Related]
13. Oral zinc and the second eye in age-related macular degeneration.
Stur M; Tittl M; Reitner A; Meisinger V
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1225-35. PubMed ID: 8641826
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
[TBL] [Abstract][Full Text] [Related]
15. ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography.
Brancato R; Introini U; Bolognesi G; Pacelli G; Trabucchi G; Pece A
Retina; 2000; 20(2):134-42. PubMed ID: 10783945
[TBL] [Abstract][Full Text] [Related]
16. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of exudative age-related macular degeneration].
Yuzawa M
Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):875-98. PubMed ID: 11193943
[TBL] [Abstract][Full Text] [Related]
18. The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study.
Chan CK; Kempin SJ; Noble SK; Palmer GA
Ophthalmology; 1994 Feb; 101(2):289-300. PubMed ID: 7509472
[TBL] [Abstract][Full Text] [Related]
19. Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2a.
Loughnan MS; Heriot WJ; O'Day J
Aust N Z J Ophthalmol; 1992 Aug; 20(3):173-5. PubMed ID: 1280447
[TBL] [Abstract][Full Text] [Related]
20. Argon green laser treatment of peripapillary choroidal neovascular membranes.
Cialdini AP; Jalkh AE; Trempe CL; Nasrallah FP; Schepens CL
Ophthalmic Surg; 1989 Feb; 20(2):93-9. PubMed ID: 2467241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
